Ethicon's RETHINK REFLUX Registry to Assess Long-Term Safety of LINX Device
The RETHINK REFLUX Registry will evaluate the long-term safety of the LINX device over a 10-year period.
Phase III
Gastroenterology / Device
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The RETHINK REFLUX Registry is crucial for assessing the long-term safety of the LINX device, which could significantly impact its market acceptance. Monitoring the outcomes will help inform strategic decisions regarding competitive positioning against other reflux treatment options.
Recommended action
Humanexa recommends Monitor.
Analysis
Key milestones include interim safety reports and final results from the registry after the 10-year follow-up.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.